Beijing Tongrentang Co Ltd Market Cap ($5.14 Billion)
Market Cap & Net Worth: Beijing Tongrentang Co Ltd (600085)
Beijing Tongrentang Co Ltd market cap. Beijing Tongrentang Co Ltd (SHG:600085) has a market capitalization of $5.14 Billion (CN¥35.15 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #3394 globally and #432 in its home market, demonstrating a 4.91% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Tongrentang Co Ltd's stock price CN¥25.63 by its total outstanding shares 1371470262 (1.37 Billion). Also see cash efficiency ratio of Beijing Tongrentang Co Ltd for how efficiently the company converts equity into cash flow.
Beijing Tongrentang Co Ltd Market Cap History (2015–2026)
Beijing Tongrentang Co Ltd market cap history from 2015 to 2026. Data shows growth from $8.26 Billion to $5.14 Billion (0.87% CAGR). Check Beijing Tongrentang Co Ltd share price for real-time trading data and today's change.
Index Memberships
Beijing Tongrentang Co Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Shanghai Shenzhen CSI 300
CSI300
|
$4.00 Trillion | 0.13% | #122 of 285 |
Weight: Beijing Tongrentang Co Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Beijing Tongrentang Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Tongrentang Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Beijing Tongrentang Co Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.38x
Beijing Tongrentang Co Ltd's market cap is 0.38 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.44x
Beijing Tongrentang Co Ltd's market cap is 5.44 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.85 Billion | $12.09 Billion | $933.17 Million | 0.48x | 6.27x |
| 2017 | $6.06 Billion | $13.38 Billion | $1.02 Billion | 0.45x | 5.95x |
| 2018 | $5.21 Billion | $14.21 Billion | $1.13 Billion | 0.37x | 4.59x |
| 2019 | $5.49 Billion | $13.28 Billion | $985.44 Million | 0.41x | 5.57x |
| 2020 | $4.70 Billion | $12.83 Billion | $1.03 Billion | 0.37x | 4.56x |
| 2021 | $8.92 Billion | $14.60 Billion | $1.23 Billion | 0.61x | 7.27x |
| 2022 | $8.91 Billion | $15.37 Billion | $1.43 Billion | 0.58x | 6.24x |
| 2023 | $10.78 Billion | $17.86 Billion | $1.67 Billion | 0.60x | 6.46x |
| 2024 | $8.15 Billion | $18.60 Billion | $1.53 Billion | 0.44x | 5.34x |
| 2025 | $6.47 Billion | $17.26 Billion | $1.19 Billion | 0.38x | 5.44x |
Competitor Companies of 600085 by Market Capitalization
Companies near Beijing Tongrentang Co Ltd in the global market cap rankings as of November 8, 2026. Also see Beijing Tongrentang Co Ltd balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Beijing Tongrentang Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #567 globally with a market cap of $47.07 Billion USD ( CN¥321.69 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #609 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.61 |
| #567 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $47.07 Billion | CN¥50.43 |
| #609 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.80 |
Market Capitalization of Beijing Tongrentang Co Ltd (2015–2026)
Market capitalization of Beijing Tongrentang Co Ltd from 2015 to today. Between 2015 and today, Beijing Tongrentang Co Ltd's market cap moved from $8.26 Billion to $ 5.14 Billion, with a yearly change of 0.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥5.14 Billion | -20.55% |
| 2025 | CN¥6.47 Billion | -20.52% |
| 2024 | CN¥8.15 Billion | -24.41% |
| 2023 | CN¥10.78 Billion | +20.93% |
| 2022 | CN¥8.91 Billion | -0.07% |
| 2021 | CN¥8.92 Billion | +89.68% |
| 2020 | CN¥4.70 Billion | -14.36% |
| 2019 | CN¥5.49 Billion | +5.44% |
| 2018 | CN¥5.21 Billion | -14.03% |
| 2017 | CN¥6.06 Billion | +3.50% |
| 2016 | CN¥5.85 Billion | -29.13% |
| 2015 | CN¥8.26 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Beijing Tongrentang Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.14 Billion USD |
| MoneyControl | $5.14 Billion USD |
| MarketWatch | $5.14 Billion USD |
| marketcap.company | $5.14 Billion USD |
| Reuters | $5.14 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beijing Tongrentang Co Ltd
Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, … Read more